Table 1.
Results of LINE-1 ORF1p Immunostaining in Ovarian Carcinomas and Fallopian Tubal Lesions
| Ovarian carcinomas and fallopian lesions | Total cases, n | Positive (strong or moderate), n (%) | Negative (weak or no staining), n (%) | Mean H-score |
|---|---|---|---|---|
| Tissue microarrays | ||||
| HGSOC | 33 | 30 (91) | 3 (9) | 212.4 |
| Clear cell carcinoma | 37 | 24 (65) | 13 (35) | 124.7 |
| Endometrioid carcinoma | 30 | 18 (60) | 12 (40) | 113.3 |
| Whole tissue sections | ||||
| HGSOC | 12 | 12 (100) | 0 (0) | 232.9 |
| STIC | 32 | 22 (69) | 10 (31) | 175.2 |
| With HGSOC | 18 | 14 (78) | 4 (22) | 201.9 |
| Without HGSOC | 14 | 8 (57) | 6 (43) | 140.7 |
| p53 signature | 12 | 0 (0) | 12 (100) | 15.0 |
| NFT | 26 | 0 (0) | 26 (100) | 33.1 |
HGSOC, high-grade serous ovarian carcinoma; NFT, normal-appearing fallopian tube; STIC, serous tubal intraepithelial carcinoma.